Correlation Between Tempest Therapeutics and Neximmune
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Neximmune, you can compare the effects of market volatilities on Tempest Therapeutics and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Neximmune.
Diversification Opportunities for Tempest Therapeutics and Neximmune
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Tempest and Neximmune is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Neximmune go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Neximmune
If you would invest 83.00 in Tempest Therapeutics on November 1, 2024 and sell it today you would earn a total of 7.00 from holding Tempest Therapeutics or generate 8.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 5.26% |
| Values | Daily Returns |
Tempest Therapeutics vs. Neximmune
Performance |
| Timeline |
| Tempest Therapeutics |
| Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Tempest Therapeutics and Neximmune Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and Neximmune
The main advantage of trading using opposite Tempest Therapeutics and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.| Tempest Therapeutics vs. Indaptus Therapeutics | Tempest Therapeutics vs. Rezolute | Tempest Therapeutics vs. Forte Biosciences | Tempest Therapeutics vs. Sana Biotechnology |
| Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |